Nvidia and Wall Street giants ink $500B AI infrastructure mega-deal

Nvidia and Wall Street giants ink $500B AI infrastructure mega-deal

Nvidia and Wall Street giants ink $500B AI infrastructure mega-deal
Realty Income Corporation and KKR have formed a euro-denominated joint venture that is expected to own a diversified portfolio of existing European net lease real estate assets contributed by Realty Income, spanning four markets and a broad mix of industries and tenants. Capital accounts advised by KKR intend to make an initial investment of €528…
Car loan customers will find annual interest rates below 7.5 per cent, with public sector banks offering some of the cheapest options, according to data compiled by Paisabazaar. UCO Bank has the lowest starting rate in the comparison at 7.35 per cent per annum. Bank of Maharashtra and Canara Bank follow with rates starting…
Mbappe Responds to Racist Attack by Paraguayan Senator After World Cup Win Controversy Erupts Following France’s World Cup Victory By Rohith Nair Incident Overview MIAMI, July 6 (Reuters) – France striker Kylian Mbappe hit back at a Paraguayan senator, describing her as a “despicable woman” on Monday after she launched a racist attack on him…
Those views come as new US tariff threats cloud Canada’s housing outlook, with US President Donald Trump having announced 50% tariffs on a range of Canadian goods set to take effect August 19. Wages and where the jobs were gained Average hourly wages rose 2.8% year-over-year in July, according to Statistics Canada, decelerating from 3.3%…
Market moving news for Asian trading on Thursday, September 24, 2026, Xi arrived in the US for Thursday’s summit with Trump as the US-China trade truce was extended to January 10. Japan reopened with the Nikkei up and JGB futures down, while Australian unemployment rose to 4.6% despite strong hiring. Oil dipped small.
An experimental personalized cancer vaccine from Merck and Moderna showed positive initial results in its first-ever late-stage trial, the companies announced Wednesday, bringing them one step closer to filing for approval of the treatment option. The mRNA-based shot in combination with Merck’s immunotherapy Keytruda met key goals in the phase three trial in more than…